COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 302: Articles 3011-3020  | Next

Ischemic Stroke after Bivalent COVID-19 Vaccination: A Self-Controlled Case Series Study
Xu, S., Sy, L. S., Hong, V., Holmquist, K. J., Qian, L., Farrington, P., Bruxvoort, K. J., Klein, N. P., Fireman, B., Han, B., Lewin, B. J.
10.1101/2023.10.12.23296968 — Posted: 2023-10-15
Longitudinal viscosity of blood plasma for rapid COVID-19 prognostics
Illibauer, J., Clodi-Seitz, T., Zoufaly, A., Aberle, J. H., Weninger, W. J., Foedinger, M., Elsayad, K.
10.1101/2023.10.13.23297016 — Posted: 2023-10-15
Hyperglycemia-induced cathepsin L maturation: Implications for diabetic comorbidities and COVID-19 susceptibility
He, Q., Zhao, M.-M., Li, M.-J., Li, X.-Y., Jin, J.-M., Feng, Y.-M., Zhang, L., Huang, W. J., Yang, F., Yang, J.-K.
10.1101/2023.10.15.23297013 — Posted: 2023-10-15
IFIH1 loss-of-function predisposes to inflammatory and SARS-CoV-2-related infectious diseases
Najm, R., Yavus, L., Jain, R., El Naofal, M., Ramaswamy, S., Abuhammour, W., Loney, T., Nowotny, N., Alsheikh-Ali, A., Abou Tayoun, A., Kandasamy, R.
10.1101/2023.10.13.23297034 — Posted: 2023-10-15
Surveillance and Stability of SARS-CoV-2 Wastewater Samples in Minnesota
Osborn, M., Champeau, S., Meyer, C., Hayden, M., Landini, L., Stark, S., Preeket, S., Vetter, S., Lynfield, R., Huff, D., Schacker, T., Doss, C. R.
10.1101/2023.10.14.23296666 — Posted: 2023-10-15
Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial
Zhang, B., Fong, Y., Fintzi, J., Chu, E., Janes, H. E., Carpp, L. N., Kenny, A., Carone, M., Benkeser, D., van der Laan, L. W. P., Deng, W., Zhou, H., Wang, X., Lu, Y., Yu, C., Borate, B., Houchens, C. R., Martins, K., Jayashankar, L., Huynh, C., Fichtenbaum, C. J., Kalams, S., Gay, C. L., Andrasik, M. P., Kublin, J. G., Corey, L., Neuzil, K. M., Priddy, F., Das, R., Girard, B., El Sahly, H. M., Baden, L. R., Donis, R. O., Koup, R. A., Gilbert, P. B., Follmann, D., United States Government (USG) COVID-19 Immune Assays Team, , Moderna, Inc. Team, , Coronavirus Vaccine Prevention Network (CoVP
10.1101/2023.10.15.23295628 — Posted: 2023-10-15
Resolving the pharmacological redox-sensitivity of SARS-CoV-2 PLpro in drug repurposing screening enabled identification of the competitive GRL-0617 binding site inhibitor CPI-169
Kuzikov, M., Morasso, S., Reinshagen, J., Wolf, M., Monaco, V., Cozzolino, F., Grdadolnik, S. G., Sket, P., Plavec, J., Iaconis, D., Summa, V., Esposito, F., Tramontano, E., Monti, M., Beccari, A. R., Windshugel, B., Gribbon, P., Storici, P., Zaliani, A.
10.1101/2023.10.11.561987 — Posted: 2023-10-15
Hidden evolutionary constraints dictate the retention of coronavirus accessory genes
Goldstein, S. A., Feeley, T. M., Babler, K. M., Hilbert, Z. A., Downhour, D. M., Moshiri, N., Elde, N. C.
10.1101/2023.10.12.561935 — Posted: 2023-10-14
Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein driving the genesis of Omicron variants
Yan, Q., Gao, X., Liu, B., Hou, R., He, P., Ma, Y., Zhang, Y., Zhang, Y., Li, Z., Chen, Q., Wang, J., Huang, X., Liang, H., Chen, X., Niu, X., He, J., Chen, L., Zhao, J., Xiong, X.
10.1101/2023.10.12.561995 — Posted: 2023-10-14
Nanobodies against SARS-CoV-2 non-structural protein Nsp9 inhibit viral replication by targeting innate immunity
Venit, T., Blavier, J., Maseko, S. B., Shu, S., Espada, L., Breunig, C., Holthoff, H.-P., Desbordes, S. C., Lohse, M., Esposito, G., Twizere, J.-C., Percipalle, P.
10.1101/2023.10.12.561992 — Posted: 2023-10-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).